Nagai Noriaki, Ito Yoshimasa, Takeuchi Noriko, Usui Shigeyuki, Hirano Kazuyuki
School of Pharmacy, Kindai University, Osaka, Japan.
Biol Pharm Bull. 2008 Nov;31(11):1990-5. doi: 10.1248/bpb.31.1990.
We previously found that the increases in Ca2+ content in the lenses of three hereditary cataract model rats, UPL rat (UPLR), Shumiya cataract rat (SCR) and Ihara cataract rat (ICR), are inhibited by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase, and that the mechanisms of Ca2+ enhancement in these rat models differ. In this study, we compare the mechanisms for dysfunction in Ca2+ regulation in UPLR, SCR and ICR. Decreases in the activity of Ca2+-ATPase were found in the lenses of SCR and ICR concurrent with cataract development. In contrast, the Ca2+-ATPase activity in UPLR with opaque lenses was higher than in those with transparent lenses. On the other hand, ATP levels were markedly decreased in UPLR with opaque lenses. The expression of cytochrome c oxidase (CCO)-1 mRNA and CCO activity in UPLR lenses was found to decrease during cataract development. The nitric oxide (NO) and lipid peroxide levels were also increased in the lenses of UPLR, SCR and ICR with opaque lenses. In UPLR, excessive NO may cause damage to the mitochondrial genome, resulting in a decrease in ATP production and increase in Ca2+-ATPase activity. The decrease in ATP content may cause the decrease in Ca2+-ATPase function resulting in the elevation in lens Ca2+. In SCR and ICR, excessive NO may cause an enhancement of lipid peroxidation resulting in the oxidative inhibition of Ca2+-ATPase. The decrease in Ca2+-ATPase activity may cause the elevation in the level of lens Ca2+, thus leading to lens opacification. Our findings show that the Ca2+ contents in the cataractous lenses of all three model rats are increased, the mechanisms for this Ca2+ enhancement is different in each rat model.
我们先前发现,三种遗传性白内障模型大鼠(UPL大鼠(UPLR)、舒米亚白内障大鼠(SCR)和伊原白内障大鼠(ICR))晶状体中Ca2+含量的增加受到诱导型一氧化氮合酶选择性抑制剂氨基胍的抑制,并且这些大鼠模型中Ca2+增强的机制有所不同。在本研究中,我们比较了UPLR、SCR和ICR中Ca2+调节功能障碍的机制。在SCR和ICR的晶状体中,随着白内障的发展,Ca2+-ATP酶活性降低。相比之下,晶状体混浊的UPLR中Ca2+-ATP酶活性高于晶状体透明的UPLR。另一方面,晶状体混浊的UPLR中ATP水平显著降低。发现在白内障发展过程中,UPLR晶状体中细胞色素c氧化酶(CCO)-1 mRNA表达和CCO活性降低。晶状体混浊的UPLR、SCR和ICR中一氧化氮(NO)和脂质过氧化物水平也升高。在UPLR中,过量的NO可能会导致线粒体基因组损伤,导致ATP生成减少和Ca2+-ATP酶活性增加。ATP含量的降低可能导致Ca2+-ATP酶功能下降,从而导致晶状体Ca2+升高。在SCR和ICR中,过量的NO可能会导致脂质过氧化增强,从而导致Ca2+-ATP酶的氧化抑制。Ca2+-ATP酶活性的降低可能会导致晶状体Ca2+水平升高,从而导致晶状体混浊。我们的研究结果表明,所有三种模型大鼠白内障晶状体中的Ca2+含量均升高,每种大鼠模型中Ca2+增强的机制不同。